Wogonoside induces cell cycle arrest and differentiation by affecting expression and subcellular localization of PLSCR1 in AML cells

Blood

Volumn 121, Issue 18, 2013, Pages 3682-3691

  Chen, Yan ^a   Hui, Hui ^a   Yang, Hao ^a   Zhao, Kai ^a   Qin, Yansu ^a   Gu, Cong ^b   Wang, Xiaotang ^a   Lu, Na ^a   Guo, Qinglong ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b YANGZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BETA ACTIN; CYCLIN A; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN E; FLAVONOID; GENOMIC DNA; LAMIN B; MEMBRANE PROTEIN; MESSENGER RNA; PHOSPHOLIPID SCRAMBLASE 1; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; WOGONOSIDE; FLAVANONE DERIVATIVE; GLUCOSIDE; PHOSPHOLIPID TRANSFER PROTEIN; PLSCR1 PROTEIN, HUMAN;

ACUTE GRANULOCYTIC LEUKEMIA; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CELL CYCLE ARREST; CELL DIFFERENTIATION; CELL NUCLEUS; CELLULAR DISTRIBUTION; CHROMATIN CONDENSATION; CONTROLLED STUDY; DOWN REGULATION; G1 PHASE CELL CYCLE CHECKPOINT; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; ACTIVE TRANSPORT; ANIMAL; BAGG ALBINO MOUSE; CELL CYCLE CHECKPOINT; CELL STRAIN HL 60; CELL STRAIN U937; DRUG EFFECT; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE; MOUSE MUTANT; NUDE MOUSE; PATHOLOGY; PROTEIN TRANSPORT; TISSUE DISTRIBUTION;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; ANTINEOPLASTIC AGENTS; CELL CYCLE CHECKPOINTS; CELL DIFFERENTIATION; CELL NUCLEUS; FLAVANONES; GENE EXPRESSION REGULATION, LEUKEMIC; GLUCOSIDES; HL-60 CELLS; HUMANS; LEUKEMIA, MYELOID, ACUTE; MICE; MICE, INBRED BALB C; MICE, NUDE; MICE, SCID; PHOSPHOLIPID TRANSFER PROTEINS; PROTEIN TRANSPORT; TISSUE DISTRIBUTION; U937 CELLS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MLCS; MLOWN;

EID: 84879699014     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-11-466219     Document Type: Article

References (49)

1. Löwenberg B, Downing JR, Burnett A. Acute myeloid leukemia. N Engl J Med. 1999;341(14): 1051-1062. (Pubitemid 29451802)
2. Hamadani M, Awan FT. Remission induction, consolidation and novel agents in development for adults with acute myeloid leukaemia. Hematol Oncol. 2010;28(1):3-12.
3. Genoux E, Nicolle E, Boumendjel A. Flavonoids as anticancer agents: recent progress and state of the art? Curr Org Chem. 2011;15(15):2608-2615.
4. Han J, Ye M, Xu M, Sun J, Wang B, Guo D. Characterization of flavonoids in the traditional Chinese herbal medicine-Huangqin by liquid chromatography coupled with electrospray ionization mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2007;848(2): 355-362. (Pubitemid 46453306)
5. Tai MC, Tsang SY, Chang LY, Xue H. Therapeutic potential of wogonin: a naturally occurring flavonoid. CNS Drug Rev. 2005;11(2):141-150. (Pubitemid 41278978)
6. Ikemoto S, Sugimura K, Yoshida N, Yasumoto R, Wada S, Yamamoto K, Kishimoto T. Antitumor effects of Scutellariae radix and its components baicalein, baicalin, and wogonin on bladder cancer cell lines. Urology. 2000;55(6):951-955. (Pubitemid 30330816)
7. Baumann S, Fas SC, Giaisi M, et al. Wogonin preferentially kills malignant lymphocytes and suppresses T-cell tumor growth by inducing PLCgamma1- and Ca2+-dependent apoptosis. Blood. 2008;111(4):2354-2363. (Pubitemid 351451444)
8. Li C, Lin G, Zuo Z. Pharmacological effects and pharmacokinetics properties of Radix Scutellariae and its bioactive flavones. Biopharm Drug Dispos. 2011;32(8):427-445.
9. Walle T. Absorption and metabolism of flavonoids. Free Radic Biol Med. 2004;36(7):829-837. (Pubitemid 38401062)
10. Lim BO. Effects of wogonin, wogonoside, and 3,5,7,2′,6′- pentahydroxyflavone on chemical mediator production in peritoneal exduate cells and immunoglobulin E of rat mesenteric lymph node lymphocytes. J Ethnopharmacol. 2003; 84(1):23-29. (Pubitemid 36034232)
11. Chen Y, Lu N, Ling Y, et al. Wogonoside inhibits lipopolysaccharide- induced angiogenesis in vitro and in vivo via toll-like receptor 4 signal transduction. Toxicology. 2009;259(1-2):10-17.
12. Sahu SK, Gummadi SN, Manoj N, Aradhyam GK. Phospholipid scramblases: an overview. Arch Biochem Biophys. 2007;462(1):103-114. (Pubitemid 46755145)
13. Zhou Q, Zhao J, Wiedmer T, Sims PJ. Normal hemostasis but defective hematopoietic response to growth factors in mice deficient in phospholipid scramblase 1. Blood. 2002;99(11):4030-4038. (Pubitemid 35332044)
14. Yokoyama A, Yamashita T, Shiozawa E, et al. MmTRA1b/phospholipid scramblase 1 gene expression is a new prognostic factor for acute myelogenous leukemia. Leuk Res. 2004;28(2): 149-157. (Pubitemid 37487994)
15. Zhang K, Guo QL, You QD, et al. Wogonin induces the granulocytic differentiation of human NB4 promyelocytic leukemia cells and up-regulates phospholipid scramblase 1 gene expression. Cancer Sci. 2008;99(4):689-695. (Pubitemid 351448072)
16. Mu R, Qi Q, Gu H, et al. Involvement of p53 in oroxylin A-induced apoptosis in cancer cells. Mol Carcinog. 2009;48(12):1159-1169.
17. Hussong JW, Rodgers GM, Shami PJ. Evidence of increased angiogenesis in patients with acute myeloid leukemia. Blood. 2000;95(1):309-313. (Pubitemid 30017257)
18. Hoang TC, Bui TK, Taguchi T, Watanabe T, Sato Y. All-trans retinoic acid inhibits KIT activity and induces apoptosis in gastrointestinal stromal tumor GIST-T1 cell line by affecting on the expression of survivin and Bax protein. J Exp Clin Cancer Res. 2010;29:165.
19. Gan FF, Nagle AA, Ang X, et al. Shogaols at proapoptotic concentrations induce G(2)/M arrest and aberrant mitotic cell death associated with tubulin aggregation. Apoptosis. 2011;16(8): 856-867.
20. Nishioka C, Ikezoe T, Yang J, Koeffler HP, Yokoyama A. Blockade of mTOR signaling potentiates the ability of histone deacetylase inhibitor to induce growth arrest and differentiation of acute myelogenous leukemia cells. Leukemia. 2008;22(12):2159-2168.
21. Herrmann H, Kneidinger M, Cerny-Reiterer S, et al. The Hsp32 inhibitors SMA-ZnPP and PEG-ZnPP exert major growth-inhibitory effects on D34+/CD38+ and CD34+/CD38- AML progenitor cells. Curr Cancer Drug Targets. 2012; 12(1):51-63.
22. Tian K, Yang S, Ren Q, et al. p38 MAPK contributes to the growth inhibition of leukemic tumor cells mediated by human umbilical cord mesenchymal stem cells. Cell Physiol Biochem. 2010;26(6):799-808.
23. Moosavi MA, Yazdanparast R, Lotfi A. 3-Hydrogenkwadaphnin induces monocytic differentiation and enhances retinoic acid-mediated granulocytic differentiation in NB4 cell line. J Biochem Mol Biol. 2006;39(6):722-729. (Pubitemid 44892898)
24. Abaza L, Talorete TP, Yamada P, Kurita Y, Zarrouk M, Isoda H. Induction of growth inhibition and differentiation of human leukemia HL-60 cells by a Tunisian gerboui olive leaf extract. Biosci Biotechnol Biochem. 2007;71(5):1306-1312. (Pubitemid 47164252)
25. Zhang HW, Yang Y, Zhang K, et al. Wogonin induced differentiation and G1 phase arrest of human U-937 leukemia cells via PKCdelta phosphorylation. Eur J Pharmacol. 2008;591(1-3): 7-12.
26. Chen Y, Lu N, Ling Y, Wang L, You Q, Li Z, Guo Q. LYG-202, a newly synthesized flavonoid, exhibits potent anti-angiogenic activity in vitro and in vivo. J Pharmacol Sci. 2010;112(1):37-45.
27. Smith J, Bunaciu RP, Reiterer G, Coder D, George T, Asaly M, Yen A. Retinoic acid induces nuclear accumulation of Raf1 during differentiation of HL-60 cells. Exp Cell Res. 2009; 315(13):2241-2248.
28. Ping J, Li JT, Liao ZX, Shang L, Wang H. Indole-3-carbinol inhibits hepatic stellate cells proliferation by blocking NADPH oxidase/reactive oxygen species/p38 MAPK pathway. Eur J Pharmacol. 2011;650(2-3):656-662.
29. Zhao KW, Li X, Zhao Q, et al. Protein kinase Cdelta mediates retinoic acid and phorbol myristate acetate-induced phospholipid scramblase 1 gene expression: its role in leukemic cell differentiation. Blood. 2004;104(12): 3731-3738. (Pubitemid 39564451)
30. Huang C, Cao J, Huang KJ, Zhang F, Jiang T, Zhu L, Qiu ZJ. Inhibition of STAT3 activity with AG490 decreases the invasion of human pancreatic cancer cells in vitro. Cancer Sci. 2006; 97(12):1417-1423. (Pubitemid 44614996)
31. Vermeulen K, Van Bockstaele DR, Berneman ZN. The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif. 2003;36(3):131-149. (Pubitemid 36808270)
32. Huang Y, Zhao Q, Zhou CX, et al. Antileukemic roles of human phospholipid scramblase 1 gene, evidence from inducible PLSCR1-expressing leukemic cells[published correction appears in Oncogene. 2006;25(54):7224]. Oncogene. 2006; 25(50):6618-6627. (Pubitemid 44646189)
33. Chen MH, Ben-Efraim I, Mitrousis G, Walker-Kopp N, Sims PJ, Cingolani G. Phospholipid scramblase 1 contains a nonclassical nuclear localization signal with unique binding site in importin alpha. J Biol Chem. 2005;280(11): 10599-10606. (Pubitemid 40395921)
34. Zhou Q, Ben-Efraim I, Bigcas JL, Junqueira D, Wiedmer T, Sims PJ. Phospholipid scramblase 1 binds to the promoter region of the inositol 1,4,5-triphosphate receptor type 1 gene to enhance its expression. J Biol Chem. 2005; 280(41):35062-35068. (Pubitemid 41504641)
35. Zhou Q, Zhao J, Al-Zoghaibi F, Zhou A, Wiedmer T, Silverman RH, Sims PJ. Transcriptional control of the human plasma membrane phospholipid scramblase 1 gene is mediated by interferon-alpha. Blood. 2000;95(8):2593-2599. (Pubitemid 30210538)
36. Nakamaki T, Okabe-Kado J, Yamamoto-Yamaguchi Y, Hino K, Tomoyasu S, Honma Y, Kasukabe T. Role of MmTRA1b/phospholipid scramblase1 gene expression in the induction of differentiation of human myeloid leukemia cells into granulocytes. Exp Hematol. 2002;30(5): 421-429. (Pubitemid 34556733)
37. Zhao KW, Li D, Zhao Q, Huang Y, Silverman RH, Sims PJ, Chen GQ. Interferon-alpha-induced expression of phospholipid scramblase 1 through STAT1 requires the sequential activation of protein kinase Cdelta and JNK. J Biol Chem. 2005;280(52):42707-42714. (Pubitemid 43049230)
38. Muñoz-Alonso MJ, Acosta JC, Richard C, Delgado MD, Sedivy J, León J. p21Cip1 and p27Kip1 induce distinct cell cycle effects and differentiation programs in myeloid leukemia cells. J Biol Chem. 2005;280(18):18120-18129. (Pubitemid 41389057)
39. Gustafson WC, Weiss WA. Myc proteins as therapeutic targets. Oncogene. 2010;29(9): 1249-1259.
40. Hoffman B, Amanullah A, Shafarenko M, Liebermann DA. The proto-oncogene c-myc in hematopoietic development and leukemogenesis. Oncogene. 2002;21(21):3414-3421. (Pubitemid 34587713)
41. Wiedmer T, Zhao J, Nanjundan M, Sims PJ. Palmitoylation of phospholipid scramblase 1 controls its distribution between nucleus and plasma membrane. Biochemistry. 2003;42(5): 1227-1233. (Pubitemid 36184063)
42. Ben-Efraim I, Zhou Q, Wiedmer T, Gerace L, Sims PJ. Phospholipid scramblase 1 is imported into the nucleus by a receptor-mediated pathway and interacts with DNA. Biochemistry. 2004; 43(12):3518-3526. (Pubitemid 38391707)
43. Chen CW, Sowden M, Zhao Q, Wiedmer T, Sims PJ. Nuclear phospholipid scramblase 1 prolongs the mitotic expansion of granulocyte precursors during G-CSF-induced granulopoiesis. J Leukoc Biol. 2011;90(2):221-233.
44. Mikoshiba K. IP3 receptor/Ca2+ channel: from discovery to new signaling concepts. J Neurochem. 2007;102(5):1426-1446. (Pubitemid 47256212)
45. Acharya JK, Jalink K, Hardy RW, Hartenstein V, Zuker CS. InsP3 receptor is essential for growth and differentiation but not for vision in Drosophila. Neuron. 1997;18(6):881-887. (Pubitemid 27274607)
46. Clark RA, Li SL, Pearson DW, et al. Regulation of calreticulin expression during induction of differentiation in human myeloid cells. Evidence for remodeling of the endoplasmic reticulum. J Biol Chem. 2002;277(35):32369-32378. (Pubitemid 34969055)
47. Bradford PG, Autieri M. Increased expression of the inositol 1,4,5-trisphosphate receptor in human leukaemic (HL-60) cells differentiated with retinoic acid or dimethyl sulphoxide. Biochem J. 1991; 280(Pt 1):205-210.
48. Bradford PG, Maglich JM, Kirkwood KL. IL-1 beta increases type 1 inositol trisphosphate receptor expression and IL-6 secretory capacity in osteoblastic cell cultures. Mol Cell Biol Res Commun. 2000;3(2):73-75. (Pubitemid 30252131)
49. Bradford PG, Wang X, Jin Y, Hui P. Transcriptional regulation and increased functional expression of the inositol trisphosphate receptor in retinoic acid-treated HL-60 cells. J Biol Chem. 1992;267(29):20959-20964.